Goldman Sachs’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Goldman Sachs’s Portfolio NFH Stock Details NFH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-58,078	Closed	-$666K	–	7177
2021 Q4	$666K	Buy	58,078 +11,280	+24%	+$127K	﹤0.01%	5175
2021 Q3	$526K	Buy	+46,798	New	+$522K	﹤0.01%	5163
2021 Q2	–	Sell	-488,466	Closed	-$5.52M	–	6739
2021 Q1	$5.52M	Buy	+488,466	New	+$4.96M	﹤0.01%	3044
2019 Q3	–	Sell	-100,000	Closed	-$1.01M	–	5470
2019 Q2	$1.01M	Hold	100,000	–	–	﹤0.01%	3995
2019 Q1	$990K	Hold	100,000	–	–	﹤0.01%	4059
2018 Q4	$980K	Buy	+100,000	New	+$968K	﹤0.01%	3981

Other funds holding NFH

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Goldman Sachs's NFH Position: Q1 2022 in Review

Goldman Sachs sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 58,078 shares — an estimated $666K sold.

Goldman Sachs first reported a position in NFH in Q4 2018 and held it in 6 quarters. The position peaked at $5.52M in Q1 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

Goldman Sachs reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Goldman Sachs sold 58,078 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $666K.
Goldman Sachs first reported a position in New Frontier Health Corporation Ordinary Shares in Q4 2018 and held it in 6 quarters.
Goldman Sachs's New Frontier Health Corporation Ordinary Shares position peaked at $5.52M in Q1 2021.
2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.